Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

NCT03971110 ·Status: TERMINATED ·Phase: PHASE4

A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer

NCT03450109 ·Status: COMPLETED ·Phase: PHASE1

Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

NCT00767286 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy

NCT02382094 ·Status: COMPLETED ·Phase: PHASE3

Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer

NCT00582842 ·Status: COMPLETED

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

NCT06274047 ·Status: RECRUITING ·Phase: PHASE3

Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

NCT05140512 ·Status: COMPLETED ·Phase: PHASE1

A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer

NCT03193060 ·Status: COMPLETED

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

NCT00237146 ·Status: COMPLETED ·Phase: PHASE4

Quality of Life and Sexuality in Patients With Prostate Cancer

NCT02961686 ·Status: WITHDRAWN

HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.

NCT02258087 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy

NCT00439751 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma

NCT04586543 ·Status: UNKNOWN ·Phase: PHASE2

Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer

NCT00669162 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

NCT00937768 ·Status: TERMINATED ·Phase: PHASE2

Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

NCT04253483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

NCT00002597 ·Status: COMPLETED ·Phase: PHASE3

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

NCT02023463 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

NCT00002633 ·Status: COMPLETED ·Phase: PHASE3

Androcur Effects on Quality of Life

NCT00908674 ·Status: COMPLETED

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer

NCT00136487 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

NCT04563936 ·Status: COMPLETED ·Phase: PHASE3

Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

NCT03927391 ·Status: COMPLETED ·Phase: PHASE4

Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

NCT00242554 ·Status: COMPLETED ·Phase: PHASE4

Ipilimumab + Androgen Depravation Therapy in Prostate Cancer

NCT01377389 ·Status: TERMINATED ·Phase: PHASE2